Quest Diagnostics Incorporated Credit Rating

Resultados 1 - 50 de 75

Página de 2 Next

Filtrar por:

Fecha	Tipo de Reporte	Título	Fuente
30 Oct 2023	Rating Action	Moody's assigns Baa2 rating to Quest Diagnostics' notes offering; positive outlook	Moody's Investors Service
25 Sep 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Business and Consumer Service issuers	Moody's Investors Service
30 May 2023	Credit Opinion	Quest Diagnostics Incorporated: Update of our credit view following revision of outlook to positive	Moody's Investors Service
24 May 2023	Rating Action	Moody's affirms Quest Diagnostics Incorporated at Baa2; revises outlook to positive	Moody's Investors Service
27 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Healthcare Service issuers	Moody's Investors Service
12 May 2022	Credit Opinion	Quest Diagnostics Incorporated: Solid performance continues as revenues normalize towards a pre-pandemic operating environment	Moody's Investors Service
14 Dec 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Quest Diagnostics Incorporated	Moody's Investors Service
28 May 2021	Credit Opinion	Quest Diagnostics Incorporated: Update to credit analysis - Base business recovery offsets drop in COVID-19 testing volumes	Moody's Investors Service
03 Feb 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Quest Diagnostics Incorporated	Moody's Investors Service
11 May 2020	Rating Action	Moody's assigns Baa2 rating to Quest Diagnostics' notes offering	Moody's Investors Service
08 May 2020	Credit Opinion	Quest Diagnostics Incorporated: Update to credit analysis - Coronavirus pandemic will hurt earnings but Covid-19 testing represents an opportunity	Moody's Investors Service
06 May 2020	Rating Action	Moody's affirms Quest Diagnostics' Baa2 rating, outlook stable	Moody's Investors Service
06 Mar 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Quest Diagnostics Incorporated	Moody's Investors Service
09 Dec 2019	Rating Action	Moody's assigns Baa2 rating to Quest Diagnostics' notes offering	Moody's Investors Service
16 May 2019	Credit Opinion	Quest Diagnostics Incorporated: Update to credit analysis	Moody's Investors Service
22 Apr 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Quest Diagnostics Incorporated	Moody's Investors Service
07 Mar 2019	Rating Action	Moody's assigns Baa2 rating to Quest Diagnostics' notes offering	Moody's Investors Service
11 May 2018	Credit Opinion	Quest Diagnostics Incorporated: Update to credit analysis	Moody's Investors Service
26 Sep 2017	Announcement	Moody's: Proposed Medicare Lab Rate Cuts Would Be Credit Negative for Quest	Moody's Investors Service
26 Sep 2017	Issuer Comment	Quest Diagnostics Incorporated: Proposed Medicare Lab Rate Cuts Would Be Credit Negative	Moody's Investors Service
11 May 2017	Credit Opinion	Quest Diagnostics Incorporated: Update of Key Rating Factors	Moody's Investors Service
24 May 2016	Credit Opinion	Quest Diagnostics Incorporated: Update of key rating factors following affirmation of Baa2 rating	Moody's Investors Service
23 May 2016	Rating Action	Moody's rates Quest's senior notes Baa2; affirms Baa2 rating on existing debt; outlook is stable	Moody's Investors Service
16 Mar 2016	Announcement	Moody's: Quest's bond tender offer is modestly credit positive; rating not impacted	Moody's Investors Service
16 Mar 2016	Issuer Comment	Quest Diagnostics Incorporated: Quest's bond tender offer is modestly credit positive; rating not impacted	Moody's Investors Service
20 Nov 2015	Credit Opinion	Quest Diagnostics Incorporated	Moody's Investors Service
01 Apr 2015	Sector Comment	Sector Comment: US Healthcare: Laboratory and Pharmaceutical Services: Quest and Quintiles JV Furthers Tie-Ups Between Labs and CROs	Moody's Investors Service
05 Mar 2015	Rating Action	Moody's rates Quest's proposed sr. notes Baa2	Moody's Investors Service
12 Mar 2014	Rating Action	Moody's rates Quest's proposed sr. notes Baa2	Moody's Investors Service
27 Jan 2014	Issuer Comment	Quest's Acquisition of Solstas Is Credit Negative	Moody's Investors Service
22 Jan 2014	Issuer Comment	Quest's announced acquisition of Solstas is credit negative	Moody's Investors Service
22 Jan 2014	Announcement	Moody's: Quest's announced acquisition of Solstas is credit negative	Moody's Investors Service
19 Nov 2012	Announcement	Moody's: negative credit impact of Quest's dividend increase not enough to affect rating	Moody's Investors Service
19 Nov 2012	Issuer Comment	Negative credit impact of Quest's dividend increase not enough to affect rating	Moody's Investors Service
08 Dec 2011	Analysis	Quest Diagnostics Incorporated	Moody's Investors Service
21 Mar 2011	Rating Action	Moody's assigns Baa2 to Quest's new notes	Moody's Investors Service
18 Mar 2011	Announcement	Moody's comments that Quest's announced acquisition of Celera has no immediate rating impact	Moody's Investors Service
18 Mar 2011	Issuer Comment	Moody's comments that Quest's announced acquisition of Celera has no immediate rating impact	Moody's Investors Service
24 Feb 2011	Announcement	Moody's comments that Quest's announced acquisition of Athena Diagnostics has no immediate rating impact	Moody's Investors Service
24 Feb 2011	Issuer Comment	Moody's comments that Quest's announced acquisition of Athena Diagnostics has no immediate rating impact	Moody's Investors Service
01 Feb 2011	Issuer Comment	Moody's comments that Quest's announced repurchase of 15.4 million shares has no immediate rating impact	Moody's Investors Service
01 Feb 2011	Announcement	Moody's says Quest's repurchase of 15.4 million shares has no immediate impact on its Baa2 unsecured rating	Moody's Investors Service
09 Feb 2010	Rating Action	Moody's upgrades Quest Diagnostics' senior notes to Baa2; outlook stable	Moody's Investors Service
12 Nov 2009	Rating Action	Moody's rates Quest's new senior notes Baa3; outlook remains positive	Moody's Investors Service
21 Sep 2009	Rating Action	Moody's changes Quest's outlook to positive; Baa3 affirmed	Moody's Investors Service
15 Apr 2009	Issuer Comment	Moody's says Quest's rating unaffected by recent developments	Moody's Investors Service
15 Apr 2009	Announcement	Moody's says Quest's rating unaffected by recent developments	Moody's Investors Service
13 Jul 2007	Covenant Quality Assessment	Quest Diagnostics Incorporated - $375 million 6.40% Senior Notes due 2017; $425 million 6.95% Senior Notes due 2037	Moody's Investors Service
13 Jul 2007	Covenant Quality Assessment	Quest Diagnostics Incorporated - $275 million 7.5% Senior Notes due 2011; $400 million 5.125% Senior Notes due 2010; $500 million 5.45% Senior Notes due 2015	Moody's Investors Service
22 Jun 2007	Rating Action	Moody's rates the proposed Senior Unsecured Notes of Quest Diagnostics, Inc. Baa3	Moody's Investors Service

Resultados 1 - 50 de 75

Página de 2 Next

Estudios & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: